News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Epigenomics AG: Pareto and Warburg publish analyst research reports

EQS-News: Epigenomics AG / Key word(s): Research UpdateEpigenomics AG: Pareto and Warburg publish analyst research reports 05.09.2023 / 17:20 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Pareto and Warburg publish analyst research reports Analysts consider acceptance of New Day Diagnostics’ purchase offer advantageous for shareholders Buy recommendation with price […]

Read more

Epigenomics AG publishes financial results for the first six months 2023

EQS-News: Epigenomics AG / Key word(s): Half Year Report/Half Year ResultsEpigenomics AG publishes financial results for the first six months 2023 10.08.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first six months 2023 Berlin (Germany), August 10, 2023 – Epigenomics AG (FSE: […]

Read more

Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets

EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets Acquirer is U.S. full-service diagnostics and CRO services company New Day […]

Read more

​​​​​​​Epigenomics AG Reports Financial Results for the First Quarter of 2023

EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results​​​​​​​Epigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin (Germany) and San Diego, CA (USA), May 31, […]

Read more

Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns

EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns  Berlin (Germany), May 19, 2023 -The Member […]

Read more

​​​​​​​Epigenomics AG publishes financial results for fiscal year 2022

EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual Report​​​​​​​Epigenomics AG publishes financial results for fiscal year 2022 28.04.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2022 Berlin (Germany) and San Diego, CA (U.S.A.), April 28, 2023 – Epigenomics AG (FSE: ECX, […]

Read more